tirzepatide tirzepatide FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Compounded Tirzepatide - Allied Wellness

The target dose, not the starting dose, is what reflects your prior level of receptor activation

In February 2026, HHS announced that approximately 14 previously restricted peptides are expected to return to Category 1 compounding status, a regulatory development that supports the continued availability of compounded peptides at clinics like Perfect B

For most users, no

In diabetes trials, injectable semaglutide 1 mg produced mean weight loss of 46 kg (approximately 913 lbs), while oral semaglutide 14 mg resulted in weight loss of approximately 34 kg (79 lbs)

Professional Guidance at Aestha Clinic Our comprehensive approach to GLP-1 therapy encompasses thorough initial patient assessment, individualised dosing protocols, and regular monitoring with adjustment as needed